针对DLL3的基于VHH的CAR-T细胞在小细胞肺癌模型中显示出高疗效
Han Guo1, Chunjiang Yue2, Di Ma1
1Shanghai Jiao Tong University Shanghai China.
Molecular cancer therapeutics
|February 12, 2026
概括
这项研究开发了针对小细胞肺癌 (SCLC) 的新型抗DLL3 VHH-CAR T细胞. 这些工程T细胞在实验室测试和动物模型中显示出强大的瘤杀伤能力,为DLL3表达癌症提供了有前途的新免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 小细胞肺癌 (SCLC) 具有侵略性,预后不佳,治疗方法有限.
- 德尔塔样联体3 (DLL3) 是SCLC的一个有前途的治疗点.
- 只有重链抗体 (VHH) 的可变域CAR T细胞显示出比ScFv对应物更强大的疗效.
研究的目的:
- 探索抗DLL3 VHH-CAR T细胞对SCLC的治疗潜力.
- 开发和评估人性化的VHH-CAR T细胞,以DLL3为目标.
- 评估这些工程T细胞的体外和体内疗效.
主要方法:
- 阿尔帕卡免疫和酵母显示查抗DLL3 VHHs.
- 在CAR T细胞模型中对VHH克隆的亲属性,特异性和细胞毒性评估.
- 人性化VHH序列 (1-B12) 和结果的HM-CAR T细胞的评估在体外和体内.
主要成果:
- 鉴定并描述了具有高亲和力,特异性和细胞毒性强大的抗DLL3 VHHs.
- 选择的人性化VHH (1-B12) 显示出优越的特性.
- HM-CAR T细胞表现出强大的细胞因子产生,瘤细胞细胞毒性,以及体内显著的抗瘤功效.
结论:
- 建立了有效的策略来开发DLL3特定的VHH.
- 反DLL3 VHH-CAR T细胞显示出作为DLL3表达癌症的免疫治疗方法的显著潜力.
- 这种方法支持VHH-CAR T治疗SCLC和其他DLL3+恶性瘤的临床转化.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Target Cell Response to Hormones
5.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
Cancer Cell Migration through Invadopodia
3.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Self-Efficacy
237
Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
237
Cancer Stem Cells and Tumor Maintenance
6.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K


